Does cellular iron dysregulation play a causative role in Parkinson's disease?

被引:110
|
作者
Kaur, D [1 ]
Andersen, J [1 ]
机构
[1] Buck Inst Aging Res, Novato, CA 94945 USA
关键词
Parkinson's disease; oxidative stress; iron; iron regulatory proteins; mitochondrial dysfunction; alpha-synuclein;
D O I
10.1016/j.arr.2004.01.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Selective dopaminergic cell loss in Parkinson's disease is correlated with increased levels of cellular iron. It is still hotly debated as to whether the increase in iron is an upstream event which acts to promote neurodegeneration via formation of oxidative stress or whether iron accumulates as a by-product of the neuronal cell loss. Here we review evidence for loss of iron homeostasis as a causative factor in disease-associated neurodegeneration and the primary players which may be involved. A series of recent studies suggest that iron regulatory proteins (IRPs) coordinate both cellular iron levels and energy metabolism, both of which are disrupted in Parkinson's disease (PD) and may in turn contribute to increased levels of oxidative stress associated with the disease. Iron has also been recently been implicated in promotion of alpha-synuclein aggregation either directly or via increasing levels of oxidative stress suggesting an important role for it in Lewy body formation, another important hallmark of the disease. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:327 / 343
页数:17
相关论文
共 50 条
  • [21] The iron hypothesis: does iron play a role in atherosclerosis?
    Meyers, DG
    TRANSFUSION, 2000, 40 (08) : 1023 - 1029
  • [22] The Role of Calcium and Iron Homeostasis in Parkinson's Disease
    Wang, Ji
    Zhao, Jindong
    Zhao, Kunying
    Wu, Shangpeng
    Chen, Xinglong
    Hu, Weiyan
    BRAIN SCIENCES, 2024, 14 (01)
  • [23] Role of Iron and Copper in the Pathogenesis of Parkinson’s Disease
    Gangania M.K.
    Batra J.
    Kushwaha S.
    Agarwal R.
    Indian Journal of Clinical Biochemistry, 2017, 32 (3) : 353 - 356
  • [24] The Role of Iron in NeurodegenerationProspects for Pharmacotherapy of Parkinson’s Disease
    Kurt A. Jellinger
    Drugs & Aging, 1999, 14 : 115 - 140
  • [25] Genetics of iron regulation and the possible role of iron in Parkinson's disease
    Rhodes, Shannon L.
    Ritz, Beate
    NEUROBIOLOGY OF DISEASE, 2008, 32 (02) : 183 - 195
  • [26] Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
    Damier, P
    Kastner, A
    Agid, Y
    Hirsch, EC
    NEUROLOGY, 1996, 46 (05) : 1262 - 1269
  • [27] SYSTEMIC LUPUS-ERYTHEMATOSUS - DOES DIET PLAY A CAUSATIVE ROLE
    PODELL, RN
    POSTGRADUATE MEDICINE, 1984, 75 (01) : 251 - 254
  • [28] Does tissue transglutaminase play a role in Huntington's disease?
    Lesort, M
    Chun, W
    Tucholski, J
    Johnson, GVW
    NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (01) : 37 - 52
  • [29] Does tissue transglutaminase play a role in Huntington's disease?
    Johnson, GVW
    Tucholski, J
    Lesort, M
    Bailey, CDC
    Chun, W
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 61 - 61
  • [30] Does insulin dysfunction play a role in Alzheimer's disease?
    Gasparini, L
    Netzer, WJ
    Greengard, P
    Xu, HX
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (06) : 288 - 293